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Abstract Endothelial cells play a pivotal role in the development 
of atherosclerosis. An 'activated' phenotype of these cells is man- 
ifested by signal transduction-dependent expression of genes en- 
coding cytokines, pro- and anticoagulant factors, and cell adhe- 
sion molecules. In the current study we examined the effect of 
ouabain, an inhibitor of Na+IK+-ATPase, on the process of endo- 
thelial cell activation. We demonstrated that ouabain was able to 
stimulate VCAM-1 expression and potentiate the effect of IFN-y 
on this process. Moreover, ouabain provided a complementary 
signal for either TNF or IFN-y in inducing iNOS expression. Our 
data also show, for the first time, that inhibition of Na+/K +- 
ATPase led to activation of the transcription factor, NF-~B, 
which may provide an explanation for the effects of ouabain on 
endothelial cells. 
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I. Introduction 
At sites of inflammation, endothelial cells undergo specific 
alterations in their morphology, metabolism and functions. 
This process, called endothelial ctivation, isinduced mostly by 
bacterial products and cytokines released by cells of the im- 
mune system. Changes in expression of genes during this proc- 
ess involve a complex program of intracellular signal transduc- 
tion processes and transcription events. The common feature 
of these genes is the presence of the xB DNA regulatory ele- 
ment interacting with the transcription factor NF-xB (for re- 
view, see [1]). Activation of this factor occurs in cells exposed 
to TNF, IL-1, LPS, viral infections, activators of PKC and 
reactive oxygen intermediates (ROI) [2]. Both, vascular cell 
adhesion molecule-1 (VCAM-1) and inducible nitric oxide syn- 
thase (iNOS) genes contain in their promoter regions equences 
that are recognized by NF-xB [3,4]. 
Because of the complexity of transcriptional regulation, the 
activation of cells depends not only on the repertoire of cyto- 
kines but also on the presence of other mediators as well as 
environmental conditions which may have inhibitory, permis- 
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sive or intensifying effects for the action of cytokines [5,6]. 
Na+/K+-ATPase which catalyses the active transport of Na + 
and K + across the plasma membrane, plays a fundamental role 
in maintaining cell homeostasis (for review, see [7]). Modula- 
tion of its activity directly influences membrane potential, cell 
volume, active ion transport, cellular uptake of nutrients but 
may also indirectly affect many other processes in various cell 
types. The activity of Na+/K+-ATPase is under multifactorial 
regulation by hormones, neurotransmitters, and ions. Recently, 
IL-1 and endothelin have been found to cause inhibition of 
Na+/K+-ATPase activity [8,9]. Ouabain (strophantin G), a car- 
diac glycoside, specifically binds to the extracellular part of 
Na+/K+-ATPase and inhibits its activity [10] thus allowing to 
study the involvement of this pump in various processes. Re- 
cently, a potent inhibitor of Na+/K+-ATPase has been isolated 
from human plasma and found to be indistinguishable from 
ouabain [11]. It has been proposed that endogenous ouabain 
originates from the adrenal gland [12]. Utilization of ouabain 
allowed to demonstrate hat inhibition of Na+/K+-ATPase not 
only affects basic metabolic processes but may also influence 
gene expression. It has been shown that ouabain stimulates 
TNF gene expression i  murine macrophages [13] and the ex- 
pression of GM-CSF in human embryonal fibroblasts [14]. 
Although much attention has been focused on ouabain as a 
potent regulator of vascular tone [15], little is known about its 
effect on endothelial cells or the possibility of its involvement 
in cell activation during inflammatory processes. The aim of 
our study was to examine the effect of ouabain on endothelial 
cell activation and especially on stimulation of the expression 
of VCAM-1 and iNOS. 
2. Materials and methods 
2.1. Reagents 
Recombinant human TNF was purchased from R~D Systems (Min- 
neapolis, MN). Recombinant murine IFN-)', DMEM, RPMI 1640, 
FCS were obtained from Life Technologies Ltd. (Paisley, UK). 
Ouabain (endotoxin tested), lipopolisaccharide (from E. coli, serotype 
055 : B5) and E-Toxate kit (Limulus lysate) were purchased from Sigma 
Chemical Co., (St. Louis, MO). All radiolabeled compounds were pur- 
chased from Amersham Life Science (Little Chalfont, UK). Unless 
indicated ifferently all remaining reagents were purchased from Sigma 
Chemical Co. (St. Louis, MO). 
2.2. Maintenance of cells 
Murine brain microvascular endothelial cells (MME) were a gift 
from Dr. R. Auerbach (Madison, WI). They were grown in medium 
consisting of DMEM, 20% FCS, endothelial cell growth supplement 
(30/lg/ml), 2mM glutamine and penicillin (100 U/ml) and streptomycin 
(100 pg/ml). Rat peritoneal macrophages were harvested from the per- 
itoneal cavity of adult rats 5 days after intraperitoneal injection of 10 
ml of thioglycollate broth and cultured in RPMI supplemented with 
10% FCS and antibiotics. P3881D1, murine macrophage-like c ll line 
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were cultured in RPMI 1640 supplemented with 10% FCS and antibiot- 
ics. P815, murine mastocytoma cells were maintained in DBA/2J mice 
(Jackson Laboratory, Bar Harbor, ME). The cells were passaged every 
5 to 6 days by intraperitoneal transfer of 0.1 ml ascites fluid. 
2.3. Adhesion assay 
Adhesion assay was performed as described previously [16]. P815 
cells were labeled with S]Cr and coincubated for 30 rain with MME 
monolayers pretreated for 24 h with the indicated factors. The mono- 
layers were then washed 3times with PBS to remove nonadherent cells. 
The content of each well was solubilized by adding 0.2 ml of 0.5 M 
NaOH and the level of radioactivity was determined in a Packard 
gamma counter. The percentage ofcells that adhered was calculated as: 
% of binding = labeled cells bound to monolayer 
labeled cells added to monolayer x 100. 
2.4. Flow cytometric analysis 
MME monolayers, cultured in 6-well plates, were incubated for 24 
h in RPMI 1640 supplemented with 2% FCS in the presence of factors 
as indicated. The cells were released from the plates with trypsin, 
washed twice with RPMI 1640, and incubated on ice for 45 min with 
50 ,ul of 5 x diluted hybridoma-conditioned medium containing anti- 
mouse VCAM-1 mAb (M/K 2.7.7) (ATCC). After washing, the cells 
were incubated for 30 min with 50/11 of 10 x diluted FITC-conjugated 
goat anti-rat IgG (Life Technologies Ltd.). The cells were washed twice, 
resuspended in 1 ml of medium and analyzed using the Consort 30 
program on a FACScan (Becton-Dickinson). The background fluores- 
cence was determined using cells incubated with secondary antibodies 
only. 
2.5. Nitrite assay 
Nitrite assay was performed as described previously [17]. Cells were 
cultured in 96-well plates in 100 ¢tl of appropriate culture medium. The 
medium was replaced with 100/11 of RPM1 1640 supplemented with 2% 
FCS and antibiotics and containing the factors indicated in each exper- 
iment. After 24 h incubation, nitrite concentration i  the medium was 
determined by a microplate assay. 80/~1 aliquots of the culture medium 
were incubated with equal volumes of Griess reagent at room temper- 
ature for 10 rain. The absorbance at 540 nm was measured with an 
ELISA reader. Nitrite concentration was determined by using dilutions 
of sodium nitrite in water as a standard. 
2.6. RNA preparation and Northern blot analysis 
MME were cultured in 94-mm tissue culture plates. After 15 h incu- 
bation of the cells with the factors as indicated, total RNA was prepared 
using phenol extraction method [18]. RNA samples (5 ktg) were sepa- 
rated electroforetically in 1% agarose gel under denaturing conditions 
[19]. RNA was then transferred toHybond-N membranes (Amersham, 
UK). The blots were baked at 80°C for 2 h, prehybridized overnight 
and hybridized at 68°C for 24 h to cDNA probes pecific for the murine 
macrophage iNOS (a gift from Drs. Q.-W. Xie and C. Nathan, New 
York, NY), murine VCAM-1 (a gift from L. Osborn, Cambridge, MA) 
and for 18S rRNA (kindly provided by N. Bhownick, Athens, GA). The 
probes were labeled by the Random Primers DNA Labeling System 
(Amersham, UK). Non-specifically bound radioactivity was removed 
by washing the blots in 2 x standard saline solution (SSC) at room 
temperature, followed by two subsequent washes in 2 × SSC/0.1% SDS 
at 68°C for 30 min each. The blots were then subjected to autoradiogra- 
phy at -70°C using intensifying screens. 
2. Z Nuclear extract preparation and DNA-protein botding assay 
MME cells were cultured in 94-mm culture plates. After the cells 
reached confluence the medium was changed for RPMI 1640 contain- 
ing 2% FCS and antibiotics. 24 h later, TNF or ouabain were added 
to the medium. After 1 h incubation, the monolayers were washed twice 
with ice-cold PBS, scraped from plates in 0.8 ml of ice-cold PBS and 
centrifuged at 200 × g for 5 min. Nuclear extracts were isolated using 
the method of Olnes and Kurl [20]. Protein concentration was deter- 
mined using the Lowry method. Oligonucleotide probe: 5'- 
AAGTCCGGGTTTTCCCCAACC-3', containing two repeats of NF- 
xB binding site, corresponding to -1101 to -1081 bp region of murine 
c-myc [21] was synthesized by Molecular and Macromolecular Re- 
search Center, Polish Academy of Sciences, L6dl, Poland. Aliquots of 
0.4 ng(-  2 × 104 cpm) of Y-labeled probe were incubated at room temper- 
ature with 5 ¢tg samples of nuclear proteins in the presence of 2/zg of 
poly(dI-dC) in 10/.tl of 10 mM Tris buffer (pH 7.5) containing 50 mM 
NaC1, 0.1 mM DTT, 1 mM EDTA and 10% glycerol. Some samples 
were incubated in the presence of 50-fold molar excess of specific cold 
oligonucleotide probe as a competitor. Protein DNA complexes were 
separated in a 4.5% polyacrylamide gel in 0.5 x TBE. The gels were 
dried and exposed to X-ray film at -70°C. 
3. Results 
Exposure of MME to ouabain resulted in the stimulation of 
VCAM-1 expression on the cell surface as monitored by flow 
cytometric analysis (Fig. 1). The effect of ouabain was weaker 
than that of TNF  and was similar to the effect of IFN-7.  The 
expression of VCAM-1 in MME was additionally monitored 
by the binding of P815 to M ME monolayers [16]. The effect of 
ouabain was dose dependent and the maximal stimulatory ef- 
fect was observed at a concentrat ion of  0.25 mM (Table 1). 
Efficient stimulation of iNOS in MME cells requires a dual 
signal which can be provided by a combinat ion of TNF  and 
IFN-7  [17]. We found that ouabain may serve as a costimulator 
in the activation of iNOS expression as measured by the accu- 
mulat ion of nitrite in culture medium (Fig. 2). Ouabain was 
able to substitute for either of the cytokines in this assay. The 
simultaneous treatment of MME with TNF  and ouabain re- 
suited in a high level of nitrite accumulation, comparable to 
that obtained when the cells were incubated with TNF  and 
IFN-7  (Fig. 2A). After treatment of MME with ouabain and 
IFN-),  (Fig. 2B), there was also substantial accumulation of 
nitrite although the effect was much weaker than the effect of 
ouabain/TNF.  Furthermore,  exposure of MME to TNF  and 
A . . . . . . . . .  conf~ol 
- - - -  OUA 
- -  IFN-,f 
IFN-y + OUA 
"6 
. E 
z S - -  Baokground 
"i .... Control .~ TNF _m 
""".,.,%. 
F luorescence  In tens i ty  
Fig. 1. Flow cytometric analysis of VCAM-1 expression i MME cells. 
(A) Cells were incubated for 24 h with medium alone (control); ouabain 
(0.25 mM); IFN-7 (200 U/ml) or with IFN-7 (200 U/ml) in the presence 
of ouabain (0.25 mM); (B) Cells were incubated for 24 h with medium 
alone (control) or TNF (2 ng/ml). Background level of fluorescence 
represents staining of cells incubated only with secondary antibodies 
(see section 2). Data are from a single experiment representative of 
3 experiments. 
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Fig. 2. Accumulation of nitrite in MME culture medium. (A) MME were stimulated for 24 h with TNF (2 ng/ml) in the presence of different 
concentrations of ouabain; (B) MME were stimulated for 24 h with IFN-y (200 U/ml) in the presence of different concentrations of ouabain; 
(C) MME were stimulated for 24 h with TNF (2 ng/ml) + IFN-y (200 U/ml) in the presence ofdifferent concentrations of ouabain. Bars represent 
means + S.D. of 5 experiments and each determination was done in triplicate. 
IFN-y in the presence of ouabain led to even higher nitrite 
production than in cells treated only with cytokines (Fig. 2C). 
The same range of concentrations of ouabain was effective for 
stimulation of nitrite accumulation as for enhancement of
VCAM-1 expression. 
The synthesis of large amounts of nitric oxide by iNOS and 
significantly increased levels of VCAM-1 in the cell membrane 
of MME are always preceded by stimulation of the expression 
of genes encoding these proteins [16,17]. This observation sug- 
gested that ouabain is able to stimulate VCAM-1 gene expres- 
sion and also that this factor could act as a costimulator in the 
activation of transcription of the iNOS gene. Northern blot 
analyses of RNA isolated from MME incubated for 15 h with 
TNF, IFN-y and ouabain confirmed this hypothesis. Ouabain 
strongly potentiated the effect of TNF on iNOS expression. 
Moreover, neither ouabain alone nor IFN-?' alone was able to 
induce iNOS expression i MME, but the combination of these 
two factors resulted in the high level of iNOS mRNA present 
in these cells (Fig. 3). 
The induction of VCAM-1 expression was observed in MME 
incubated with ouabain alone. The factor also enhanced the 
stimulatory effect of IFN-y on VCAM-1 expression. The obser- 
vation that the level of VCAM-1 mRNA in the cells treated 
with TNF in the presence of ouabain (0.25 mM) is lower than 
in the cells incubated with TNF alone is not surprising. MME 
exposed simultaneously to TNF and ouabain produce large 
amount of NO which is capable of inhibiting VCAM-1 gene 
expression to some extent [22]. 
The induction of VCAM-1 and iNOS gene transcription by 
cytokines involves activation of NF-xB [3,4]. We found that 
ouabain, like TNF, activates NF-xB resulting in its transloca- 
tion to the nuclei of MME cells (Fig. 4). 
4. Discussion 
In the current studies we demonstrated that ouabain acti- 
vates murine endothelial cells in culture. Ouabain was able to 
stimulate VCAM-1 expression, potentiate the effect of IFN-y 
on this process and also provide a complementary signal for 
either TNF or IFN-~, in stimulating iNOS expression. The 
effect of the drug on iNOS expression was not restricted to 
endothelial cells since ouabain acted as a costimulator f NO 
24 
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Fig. 3. Northern blot analysis ofiNOS and VCAM-1 mRNAs in MME 
cells. Cells were incubated for 15 hours with medium alone (lane A), 
with ouabain (0.125 mM) (lane B), ouabain (0.25 mM) (lane C), TNF 
(2 ng/ml) (lane D), TNF in the presence ofouabain (0.125 mM) (lane 
E), TNF in the presence of ouabain (0.25 mM) (lane F), IFN-y (200 
U/ml) (lane G), IFN-y (200 U/ml) in the presence of ouabain (0.125 
mM) (lane H), IFN-y (200 U/ml) in the presence ofouabain (0.25 mM) 
(lane J), TNF (2 ng/ml) + IFN-~, (200 U/ml) (lane K), TNF (2 ng/ml) 
+ IFN-~, (200 U/ml) in the presence of ouabain (0.25 mM) (lane L). 
Equal oading of wells with RNA samples was verified by hybridization 
with 18S rRNA-specific DNA probe. 
synthesis in rat peritoneal macrophages and P388/D1 murine 
macrophage-like cell line (data not shown). Activation of NF- 
xB observed in MME exposed to ouabain may be responsible 
for the stimulatory effects of the drug. 
We excluded the possibility that the effects of ouabain orig- 
inated from its contamination with LPS. We used endotoxin- 
free preparations of the drug and confirmed that the solutions 
of ouabain were negative for LPS in a Limulus assay. Moreo- 
ver, ouabain was able to potentiate he effect of LPS even if LPS 
was used at very high concentrations (>1 /~M) (data not 
shown). In addition, another cardiac glycoside, digoxin, had the 
same effect on VCAM-1 and iNOS expression as ouabain (data 
not shown). 
Although our results indicate that ouabain exerts its effects 
in MME through the activation of NF-xB, the intracellular 
events that follow the binding of ouabain to Na+/K+-ATPase 
are unclear at this time. It is known that elevated [Na+]i and a 
diminished sodium concentration gradient across the plasma 
membrane may influence other ion exchange systems that could 
be involved in intracellular signaling. The Na + gradient is the 
energy source for the Na*-Ca 2+ antiport, and thus ouabain 
might indirectly elevate [Ca2+]~. This mechanism which could 
explain increased contractility of the heart in response to car- 
diac glycosides [23], has also been postulated for the effects of 
these agents in other cells [24,25]. However, it has been shown 
that in some cell types, biological effects of ouabain are not 
accompanied by increased [Ca2+]i [26]. Sage et al. showed that 
ouabain did not cause elevation in [Ca2÷]i in bovine pulmonary 
artery endothelial cells [27]. It is unlikely that the stimulatory 
effect of ouabain in MME cells would be the result of increased 
[Ca2+]i, since we have previously shown that the elevation in 
[Ca2+]i in these cells by various calcium-mobilizing a ents had 
the opposite ffect and led to inhibition of cytokine-stimulated 
VCAM- 1 and iNOS expression [17]. Moreover, our preliminary 
experiments did not show any increase in 45Ca2+ uptake by 
MME cells exposed either to cytokines (TNF, IFN-~') or to 
ouabain (data not shown). Furthermore, there appear to be no 
reports showing that calcium ions activate NF-xB. Increased 
[Na +] may also influence other ion-exchange systems as for 
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example the Na+-H*antiport which is responsible for maintain- 
ing phi and which has been shown to take part in regulation 
of processes involved in growth, differentiation a d cell metab- 
olism [28]. We are currently evaluating whether ouabain exerts 
its effect on MME through an indirect modulation of activity 
of an ion-exchange systems. 
Another possibility which could explain ouabain effects is 
based on the fact that membrane-coupled ion translocation is 
an important ATP-requiring process of the cell. Different cells 
use from 5% to 50% of energy stored in ATP molecules for 
maintaining the concentration gradients of the ions [29,30]. 
Inhibition of the Na+/K+-ATPase would lead to transient dis- 
ruption in the balance between the rate of ATP synthesis and 
ATP hydrolysis catalyzed by Na+/K+-ATPase. This would re- 
sult in more ATP available to be utilized by protein kinases 
involved in the activation of transcription factors (including 
NF-xB). The level of phosphorylation f cellular proteins de- 
pends on activities of two classes of enzymes: protein kinases 
and protein phosphatases. It has been shown that inhibition of 
intracellular phosphatases by okadaic acid leads to increased 
phosphorylation of numerous proteins involved in signal 
transduction and mimics the effect of cytokines (or other pro- 
A B C D E F 
Fig. 4. Gel retardation assay of MME nuclear proteins binding to 
NF-xB. 32p-labeled oligonucleotide probe was incubated for 30 min 
with nuclear extracts isolated from MME cells exposed for 1 h to: 
medium alone (lane B), ouabain (0.25 mM) (lane C and D) or TNF (2 
ng/ml) (lane E and F). Nuclear extracts were incubated with the probe 
in the absence (lane C and E) or presence of 50-fold molar excess of 
specific old oligonucleotide probe as a competitor (lane D and F). 
Lane A contains free probe. Data are from a single xperiment repre- 
sentative of 4 distinct nuclear extracts preparations. 
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Table 1 
Adherence of P815 cells to MME monolayers a 
Stimulator % of P815 binding 
None 18.0 -t- 3 .5  b 
Ouabain: 
0.062 mM 25.7 + 4.9 
0.125 mM 30.4 + 3.8 
0.250 mM 35.9 + 4.4 
TNF 2 ng/ml 58.6 + 6.2 
IFN-y 200U/ml 29.5 ± 4.2 
a MME monolayers were incubated for 24 h with indicated factors prior 
to the adhesion assay. 
b Data represent means + S.D. of 6 experiments and each determination 
was done in triplicate. 
tein kinases activators) [31]. Similarly, increased intracellular 
levels of ATP (a substrate for kinases) may lead to the changes 
in the equilibrium between phosphorylation and dephosphor- 
ylation processes and thus promote the activation of transcrip- 
tion factors. 
In summary, we have shown that cardiac glycosides are able 
to stimulate gene expression in endothelial cells through the 
activation of NF-xB. 
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